We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients

This study is currently recruiting participants.
Verified March 2016 by vghtpe user, Taipei Veterans General Hospital, Taiwan
Sponsor:
ClinicalTrials.gov Identifier:
NCT01491295
First Posted: December 13, 2011
Last Update Posted: April 1, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Kaohsiung Medical University Chung-Ho Memorial Hospital
China Medical University Hospital
Chi Mei Medical Hospital
Chiayi Christian Hospital
Information provided by (Responsible Party):
vghtpe user, Taipei Veterans General Hospital, Taiwan
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2019
  Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)